Latest news
AXSM Stock Advances On CEO’s Pipeline Claim: One New Drug Filing Yearly Through 2030 - StocktwitsStocktwits · Mon, 10 Aug 2026 23:25:00 GMTMoonLake’s Psoriatic Arthritis Drug Shows Promise In Phase 3 Trial – Retail Shrugs Off Premarket Slide, Says ‘Pipeline Is Intact’ - StocktwitsStocktwits · Mon, 10 Aug 2026 13:24:00 GMTCMPS Stock Climbs After-Hours: Analyst Sees Depression Drug Approval By H1 2027 Or Sooner After Strong Trial Data - StocktwitsStocktwits · Sat, 08 Aug 2026 15:45:30 GMTVNDA Stock Rises After Hours On Commercial Launch Of Motion Sickness Drug - StocktwitsStocktwits · Sat, 08 Aug 2026 10:56:13 GMTTNXP Stock Dives For Four Straight Sessions — Retail Eyes Drug Pipeline Payoff - StocktwitsStocktwits · Sat, 08 Aug 2026 08:46:26 GMTReplimune’s First Commercial Drug Arrives—With A 2027 Cash Cliff And 2030 Finish Line - StocktwitsStocktwits · Sat, 08 Aug 2026 06:00:23 GMTDisc Medicine Stock Slumps After FDA Declines Approval For Inherited Disorder Drug Over Efficacy Concerns - StocktwitsStocktwits · Sat, 08 Aug 2026 05:35:45 GMTQuoin Pharmaceuticals Garners Buzz After FDA’s Comments On Netherton Syndrome Lead Drug - StocktwitsStocktwits · Fri, 07 Aug 2026 19:51:47 GMT